This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Cerus Corporation. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Krimpen Aan den Ljssel, NL (2020)
- Concord, CA (US) (2020)
Company Filing History:
Years Active: 2020
Title: Innovations of Johannes Vermeij
Introduction
Johannes Vermeij is a notable inventor based in Krimpen Aan den IJssel, Netherlands. He has made significant contributions to the field of medical technology, particularly in the preparation of platelet products and plasma compositions. With a total of 2 patents, Vermeij's work has had a substantial impact on improving healthcare solutions.
Latest Patents
Vermeij's latest patents include "Methods for preparing platelet products," which outlines improved processes for preparing and treating platelet products. These methods are designed to efficiently create platelet products with desirable characteristics, including pathogen-inactivated platelet products. Another significant patent is "Plasma compositions and methods of use thereof," which provides pathogen-inactivated plasma compositions and methods for treating diseases or conditions using these compositions.
Career Highlights
Johannes Vermeij is currently associated with Cerus Corporation, a company known for its innovative solutions in blood safety. His work at Cerus has allowed him to focus on developing advanced medical technologies that enhance patient care and safety.
Collaborations
Vermeij has collaborated with esteemed colleagues such as Laurence Corash and Richard Benjamin. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the medical field.
Conclusion
Johannes Vermeij's contributions to medical technology through his patents and collaborations highlight his commitment to improving healthcare solutions. His work continues to influence the industry and pave the way for future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile